Trial Profile
Utilization of Autologous Mesenchymal Cells to Enhance Rotator Cuff Repair - a Prospective Non-randomized, Open-Label Study to Assess the Safety and the Efficacy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Shoulder injuries
- Focus Adverse reactions
- Acronyms AMSC in RC
- Sponsors Bioinova
- 10 Oct 2014 New trial record